Afya Ltd has a consensus price target of $21.25, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from Morgan Stanley, JP Morgan, and Morgan Stanley on January 22, 2024, November 27, 2023, and October 13, 2023. With an average price target of $22.17 between Morgan Stanley, JP Morgan, and Morgan Stanley, there's an implied 34.92% upside for Afya Ltd from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
01/22/2024 | AFYA | Buy Now | Afya | $16.43 | 39.99% | Morgan Stanley | Javier Martinez | $20.5 → $23 | Downgrade | Overweight → Equal-Weight | Get Alert |
11/27/2023 | AFYA | Buy Now | Afya | $16.43 | 39.99% | JP Morgan | Marcelo Santos | $22 → $23 | Downgrade | Overweight → Neutral | Get Alert |
10/13/2023 | AFYA | Buy Now | Afya | $16.43 | 24.77% | Morgan Stanley | Javier Martinez | $16.5 → $20.5 | Upgrade | Equal-Weight → Overweight | Get Alert |
11/22/2022 | AFYA | Buy Now | Afya | $16.43 | 9.56% | Credit Suisse | Mauricio Cepeda | $19 → $18 | Maintains | Outperform | Get Alert |
04/08/2022 | AFYA | Buy Now | Afya | $16.43 | 15.64% | Credit Suisse | Mauricio Cepeda | $18 → $19 | Upgrade | Neutral → Outperform | Get Alert |
03/07/2022 | AFYA | Buy Now | Afya | $16.43 | 27.81% | UBS | Maria Tereza Azevedo | $27 → $21 | Maintains | Buy | Get Alert |
07/21/2021 | AFYA | Buy Now | Afya | $16.43 | 73.46% | Morgan Stanley | Javier Martinez | — | Downgrade | Overweight → Equal-Weight | Get Alert |
The latest price target for Afya (NASDAQ: AFYA) was reported by Morgan Stanley on January 22, 2024. The analyst firm set a price target for $23.00 expecting AFYA to rise to within 12 months (a possible 39.99% upside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for Afya (NASDAQ: AFYA) was provided by Morgan Stanley, and Afya downgraded their equal-weight rating.
The last upgrade for Afya Ltd happened on October 13, 2023 when Morgan Stanley raised their price target to $20.5. Morgan Stanley previously had an equal-weight for Afya Ltd.
The last downgrade for Afya Ltd happened on January 22, 2024 when Morgan Stanley changed their price target from $20.5 to $23 for Afya Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Afya, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Afya was filed on January 22, 2024 so you should expect the next rating to be made available sometime around January 22, 2025.
While ratings are subjective and will change, the latest Afya (AFYA) rating was a downgraded with a price target of $20.50 to $23.00. The current price Afya (AFYA) is trading at is $16.43, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.